| Literature DB >> 27809793 |
Chyongchiou J Lin1, Mary Patricia Nowalk2, Valory N Pavlik3, Anthony E Brown3,4, Song Zhang1, Jonathan M Raviotta1, Krissy K Moehling1, Mary Hawk5, Edmund M Ricci5, Donald B Middleton1, Suchita Patel6, Jeannette E South-Paul1, Richard K Zimmerman1,5.
Abstract
BACKGROUND: An evidence-based, step-by-step guide, the 4 Pillars™ Practice Transformation Program, was the foundation of an intervention to increase adult immunizations in primary care and was tested in a randomized controlled cluster trial. The purpose of this study is to report changes in influenza immunization rates and on factors related to receipt of influenza vaccine.Entities:
Keywords: Adults; Immunization; Influenza vaccine
Mesh:
Substances:
Year: 2016 PMID: 27809793 PMCID: PMC5094034 DOI: 10.1186/s12879-016-1940-1
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Randomization Scheme
Intervention strategies used to increase adult vaccination rates from the 4 pillars™ practice transformation program
| Pillar 1 | Convenient vaccination services |
| • Use every patient visit type as an opportunity to vaccinate. | |
| • Offer open access/walk-in vaccination during office hours. | |
| • Hold express vaccination clinics outside normal office hours where only influenza vaccine is offered and systems for check-in, screening, and record keeping are streamlined. | |
| • Create a dedicated vaccination station. | |
| • Extend the influenza vaccination season by vaccinating as soon as supplies arrive and continuing to vaccinate as long as flu is circulating in the community. | |
| Pillar 2 | Communication with patients about the importance of vaccination and the availability of vaccines |
| • Train staff to discuss influenza vaccine during routine processes such as vital signs | |
| • Discuss the serious nature of influenza | |
| • Promote vaccination of staff to set a good example | |
| • Record telephone on-hold messages that advertise vaccine availability or promote vaccination. | |
| • Use posters/fliers/electronic message board/website postings/social media promoting vaccination | |
| • Conduct outreach by email, phone, text, mail, health portal, etc. that vaccines are due and/or available | |
| Pillar 3 | Enhanced office systems to facilitate adult vaccination |
| • Assess vaccination eligibility for every scheduled patient at the beginning of the day and discuss in daily huddles | |
| • Assess immunizations as part of vital signs upon rooming patients and record outside vaccinations in EMR | |
| • Incorporate EMR prompts for vaccination into the workflow | |
| • Incorporate standing order programs (SOP) for vaccination by nurses and/or medical assistants into the workflow | |
| • Ensure sufficient vaccine inventory to handle increased immunizations | |
| • Promote simultaneous vaccination (e.g., offer other vaccines at the time of influenza vaccination) | |
| Pillar 4 | Motivation through an office immunization champion |
| • Create a chart to track progress. Set an improvement goal and regularly track progress (e.g., daily or weekly). Post the graph of your progress in a prominent location and update it regularly. | |
| • Provide ongoing feedback to staff on vaccination progress using email, posted notices, making announcements, or using a combination of these. Encourage, nudge, and cheer as needed to keep up the momentum. | |
| • Report upon progress at staff or huddle meetings. Facilitate discussion at these meetings to identify which pillar activities are working, which are not working and why, and to identify changes that need to be made. | |
| • Create a competitive challenge among your staff for the most vaccinations given. | |
| • Provide rewards for successful results to create a fun-spirited environment that promotes vaccination across the practice. Ideas include: reward for highest vaccinator, team competitions, vaccination goal poster contest, etc. | |
Demographic and practice characteristics by practice and intervention group at baseline
| Site |
| Age, yrs. Mean (SD) | Female, % | White, % | Non-white, % | Hispanic, % | Health insurance status | ||
|---|---|---|---|---|---|---|---|---|---|
| Medicaid,a% | Commercial, % | Medicare, % | |||||||
| Pittsburgh sites | |||||||||
| Intervention | |||||||||
| B | 529 | 65.5 (14.6) | 69.8 | 58.0 | 41.2 | 0.4 | 15.1 | 42.0 | 42.9 |
| C | 2179 | 60.1 (17.4) | 60.3 | 99.4 | 0.3 | 0.1 | 11.7 | 58.5 | 29.8 |
| D | 3224 | 66.8 (14.7) | 52.2 | 99.6 | 0.2 | 0.1 | 6.2 | 56.3 | 37.5 |
| E | 1392 | 56.5 (15.9) | 58.6 | 95.1 | 4.7 | 0.1 | 14.5 | 61.9 | 23.6 |
| G | 417 | 67.0 (14.3) | 52.0 | 82.5 | 16.6 | 0.0 | 5.3 | 49.2 | 45.6 |
| H | 306 | 66.7 (14.9) | 59.2 | 62.4 | 37.0 | 0.0 | 13.7 | 41.5 | 44.8 |
| F | 3611 | 58.1 (17.0) | 56.8 | 96.4 | 2.4 | 0.3 | 5.0 | 62.6 | 32.4 |
| J | 603 | 62.2 (18.6) | 52.7 | 85.9 | 13.3 | 0.2 | 9.0 | 61.4 | 29.7 |
| K | 330 | 56.0 (17.7) | 67.6 | 99.1 | 0.3 | 0.3 | 16.4 | 61.5 | 22.1 |
| M | 595 | 66.4 (14.9) | 51.1 | 98.0 | 0.2 | 0.3 | 6.7 | 58.8 | 34.5 |
| Total | 13,186 | 61.7 (16.7) | 56.7 | 94.3 | 5.0 | 0.2 | 10.0 | 59.4 | 30.6 |
| Control | |||||||||
| N | 2102 | 62.0 (16.4) | 58.3 | 6.6 | 0.4 | 0.1 | 8.1 | 67.5 | 24.4 |
| O | 4324 | 57.2 (16.0) | 53.9 | 98.6 | 0.7 | 0.1 | 7.4 | 65.0 | 27.6 |
| R | 2534 | 58.8 (14.6) | 52.3 | 97.8 | 1.2 | 0.2 | 4.8 | 67.6 | 27.7 |
| S | 1645 | 43.6 (16.7) | 75.1 | 53.3 | 45.7 | 0.8 | 58.4 | 23.4 | 18.2 |
| U | 2612 | 57.1 (17.3) | 63.9 | 90.9 | 7.9 | 0.3 | 11.6 | 53.0 | 35.4 |
| W | 224 | 78.6 (10.4) | 72.8 | 92.4 | 6.3 | 0.9 | 2.2 | 46.0 | 51.8 |
| X | 1010 | 53.3 (15.0) | 46.6 | 96.5 | 2.0 | 0.0 | 12.0 | 64.5 | 23.6 |
| Y | 3334 | 60.2 (15.8) | 58.9 | 97.6 | 1.7 | 0.1 | 7.9 | 60.7 | 31.5 |
| Total | 17,185 | 57.8 (16.6) | 57.8 | 94.2 | 5.8 | 0.2 | 11.1 | 60.2 | 28.7 |
| Houston sites | |||||||||
| Intervention | |||||||||
| A | 4880 | 52.6 (13.7) | 68.8 | 8.0 | 19.7 | 72.3 | 83.8 | 4.8 | 11.5 |
| I | 8527 | 53.3 (13.7) | 70.7 | 2.7 | 67.6 | 29.6 | 82.9 | 1.5 | 15.6 |
| L | 5867 | 51.9 (12.0) | 72.6 | 13.1 | 9.3 | 77.6 | 94.5 | 0.8 | 4.7 |
| Total | 19,274 | 51.0 (13.0) | 72.0 | 6.0 | 94.0 | 67.0 | 86.7 | 2.1 | 11.2 |
| Control | |||||||||
| P | 6388 | 51.8 (13.4) | 73.0 | 4.1 | 13.9 | 82.0 | 91.7 | 1.1 | 7.1 |
| T | 5547 | 50.9 (12.9) | 69.5 | 11.1 | 28.7 | 60.2 | 90.8 | 2.3 | 6.9 |
| V | 8969 | 50.7 (13.2) | 73.7 | 4.0 | 35.6 | 60.3 | 95.1 | 0.6 | 4.3 |
| Total | 20,904 | 53.0 (13.0) | 71.0 | 7.0 | 93.0 | 55.0 | 92.9 | 1.2 | 5.8 |
aAlso includes Other/self-pay/indigent/charity care
Influenza vaccination rates and missed vaccination opportunities during the Year 1 randomized controlled cluster trial by practice, intervention group and city
| Site | Total | % Vaccinated | % of Patients with ≥1 Missed Opportunities | ||||
|---|---|---|---|---|---|---|---|
| Baseline | Year 1 | PP Difference | Baseline | Year 1 | PP Difference | ||
| 8/1/2012-1/31/2013 | 8/1/2013-1/31/2014 | 8/1/2012-1/31/2013 | 8/1/2013-1/31/2014 | ||||
| Pittsburgh sites | |||||||
| Intervention | |||||||
| B | 529 | 49.0 | 50.5 | 1.5 | 79.0 | 76.0 | -3.0 |
| C | 2179 | 57.9 | 65.0 | 7.1 | 65.9 | 62.6 | -3.3 |
| D | 3224 | 54.6 | 59.3 | 4.7 | 66.1 | 64.1 | -2.0 |
| E | 1392 | 47.4 | 54.2 | 6.8 | 78.0 | 71.2 | -6.8 |
| G | 417 | 51.8 | 54.0 | 2.2 | 70.5 | 69.5 | -1.0 |
| H | 306 | 53.3 | 48.0 | -5.3 | 77.8 | 69.9 | -7.9 |
| F | 3611 | 56.0 | 60.6 | 4.6 | 66.7 | 67.0 | 0.3 |
| J | 603 | 49.1 | 54.7 | 5.6 | 70.7 | 65.7 | -5.0 |
| K | 330 | 23.6 | 30.9 | 7.3 | 91.5 | 89.4 | -2.1 |
| M | 595 | 62.0 | 68.1 | 6.1 | 66.9 | 62.2 | -4.7 |
| Total | 13,186 | 53.7 | 58.7 | 5.0*† | 69.3 | 66.8 | -2.5*† |
| Control | |||||||
| N | 2102 | 60.2 | 61.8 | 1.6 | 71.2 | 67.4 | -3.8 |
| O | 4324 | 35.3 | 50.9 | 15.6 | 76.5 | 68.9 | -7.6 |
| R | 2534 | 42.3 | 46.7 | 4.4 | 76.1 | 70.5 | -5.6 |
| S | 1045 | 35.3 | 36.0 | 0.7 | 83.8 | 81.3 | -2.5 |
| U | 2612 | 52.9 | 54.2 | 1.3 | 68.2 | 71.2 | 3.0 |
| W | 224 | 61.2 | 75.0 | 13.8 | 66.1 | 53.6 | -12.5 |
| X | 1010 | 47.2 | 56.6 | 9.4 | 72.5 | 70.1 | -2.4 |
| Y | 3334 | 54.3 | 58.2 | 3.9 | 70.6 | 68.2 | -2.4 |
| Total | 17,185 | 46.8 | 53.3 | 6.5*† | 73.4 | 69.8 | -3.6*† |
| Houston sites | |||||||
| Intervention | |||||||
| A | 4880 | 43.4 | 47.9 | 4.5 | 79.3 | 78.3 | -1.0 |
| I | 8527 | 33.2 | 37.4 | 4.2 | 82.7 | 85.0 | 2.3 |
| L | 5867 | 36.1 | 35.2 | -0.9 | 82.0 | 86.2 | 4.2 |
| Total | 19,274 | 36.7 | 39.4 | 2.7*† | 81.6 | 83.7 | 2.1*† |
| Control | |||||||
| P | 6388 | 36.6 | 46.9 | 10.3 | 82.5 | 79.8 | -2.7 |
| T | 5547 | 32.2 | 40.7 | 8.5 | 82.6 | 79.5 | -3.1 |
| V | 8969 | 47.0 | 46.4 | -0.6 | 73.8 | 76.1 | 2.3 |
| Total | 20,904 | 39.9 | 45.1 | 5.2*† | 78.8 | 78.1 | -0.7*† |
Note: PP percentage point difference between baseline and Year 1 vaccination rates and percent of patients with ≥1 missed opportunities. A decrease in missed opportunities is the desired outcome
P value is a two-sided probability from Cochran-Armitage trend test for percentage point difference between Baseline and Year 1 (P < 0.001)
† P value is a two-sided probability from chi-square test for percentage point difference between intervention and control groups (P < 0.001)
Likelihood of influenza vaccination at the end of the year 1 randomized controlled cluster trial (1/31/2014) using generalized estimating equations, by city
| Variable | Pittsburgh | Houston | ||
|---|---|---|---|---|
| Odds Ratio (95 % CI) |
| Odds Ratio (95 % CI) |
| |
| Patient level variables | ||||
| Female, ref. = male | 1.08 (1.03-1.13) | 0.002 | 0.98 (0.93-1.03) | 0.170 |
| Age, years | 1.04 (1.04-1.04) | <0.001 | 1.03 (1.03-1.03) | <0.001 |
| White race, ref. = Non-white | 1.16 (1.04-1.30) | 0.007 | -- | -- |
| Hispanic ethnicity, ref. = Non-Hispanic | -- | -- | 1.12 (1.08-1.16) | <0.001 |
| Medicaid, charity care, uninsured, ref. = Commercial insurance + Medicare | 0.97 (0.89-1.05) | 0.050 | 0.95 (0.88-1.02) | 0.153 |
| Site level variables | ||||
| Intervention, ref. = Control | 1.00 (0.95-1.05) | 0.950 | 1.06 (1.00-1.13) | 0.048 |
| Patients with ≥1 missed opportunities, % | 0.94 (0.94-0.95) | <0.001 | 0.94 (0.94-0.95) | <0.001 |
Influenza vaccination rates and missed opportunities during the year 2 pre-post study by practice, intervention group and city
| Site | Total | % Vaccinated | % Patients with ≥1 Missed Opportunities | ||||
|---|---|---|---|---|---|---|---|
| Pre | Post | PP Difference | Pre | Post | PP Difference | ||
| 8/1/2013-1/31/2014 | 8/1/2014-1/31/2015 | 8/1/2013-1/31/2014 | 8/1/2014-1/31/2015 | ||||
| Pittsburgh sites | |||||||
| Maintenance | |||||||
| B | 529 | 50.5 | 53.3 | 2.8 | 76.0 | 60.9 | -15.1 |
| C | 2179 | 65.0 | 63.4 | -1.6 | 62.6 | 60.1 | -2.5 |
| D | 3224 | 59.3 | 61.3 | 2.0 | 64.1 | 61.8 | -2.3 |
| E | 1392 | 54.2 | 49.1 | -5.1 | 71.2 | 73.2 | 2.0 |
| G | 417 | 54.0 | 62.1 | 8.2 | 69.5 | 64.3 | -5.2 |
| H | 306 | 48.0 | 50.0 | 2.0 | 69.9 | 73.2 | 3.3 |
| Total | 8047 | 55.2 | 56.5 | 1.4* | 68.9 | 65.6 | -3.3* |
| Active Intervention | |||||||
| F | 3611 | 60.6 | 65.3 | 4.7 | 67.0 | 58.7 | -8.3 |
| J | 603 | 54.7 | 54.9 | 0.2 | 65.7 | 65.3 | -0.4 |
| K | 330 | 30.9 | 28.2 | -2.7 | 89.4 | 92.4 | 3.0 |
| M | 595 | 68.1 | 79.5 | 11.4 | 62.2 | 52.6 | -9.6 |
| N | 2102 | 61.8 | 59.0 | -2.8 | 67.4 | 65.5 | -1.9 |
| O | 4324 | 50.9 | 46.3 | -4.6 | 68.9 | 68.7 | -0.2 |
| R | 2534 | 46.7 | 41.9 | -4.8 | 70.5 | 73.5 | 3.0 |
| S | 1045 | 36.0 | 40.1 | 4.1 | 81.3 | 81.4 | 0.1 |
| U | 2612 | 54.2 | 58.2 | 4.0 | 71.2 | 62.5 | -8.7 |
| W | 224 | 75.0 | 75.9 | 0.9 | 53.6 | 53.6 | 0 |
| X | 1010 | 56.6 | 59.9 | 3.3 | 70.1 | 64.0 | -6.1 |
| Y | 3334 | 58.2 | 61.8 | 3.6 | 68.2 | 59.8 | -8.4 |
| Total | 22,324 | 54.5 | 55.9 | 1.44* | 69.6 | 66.5 | -3.1* |
| Houston sites | |||||||
| Maintenance | |||||||
| A | 4880 | 47.9 | 48.4 | 0.5 | 78.3 | 79.2 | 0.9 |
| I | 8527 | 37.4 | 35.3 | -2.1 | 85.0 | 86.5 | 1.5 |
| L | 5867 | 35.2 | 40.0 | 4.9 | 86.2 | 81.6 | -4.6 |
| Total | 19,274 | 40.2 | 41.2 | 1.7*† | 83.2 | 82.4 | -0.7**† |
| Active intervention | |||||||
| P | 6388 | 46.9 | 49.8 | 2.9 | 79.8 | 75.9 | -3.9 |
| T | 5547 | 40.7 | 46.3 | 5.7 | 79.5 | 73.5 | -6.0 |
| V | 8969 | 46.4 | 48.8 | 2.4 | 76.1 | 74.9 | -1.2 |
| Total | 20,904 | 44.7 | 48.3 | 3.6*† | 78.5 | 74.8 | -3.7*† |
Note: PP Percentage point difference between pre (Year 1) and post (Year 2). A decrease in missed opportunities is the desired outcome
P value is a two-sided probability from Cochran-Armitage trend test for difference between pre and post intervention (P < 0.001)
**P value is a two-sided probability from Cochran-Armitage trend test for difference between pre and post intervention (P < 0.05)
† P value is a two-sided probability from chi-square test of PP differences between intervention arms
Likelihood of influenza vaccination at the end of the year 2 pre-post study (1/31/2015) using generalized estimating equations, by city
| Variable | Pittsburgh | Houston | ||
|---|---|---|---|---|
| Odds Ratio (95 % CI) |
| Odds Ratio (95 % CI) |
| |
| Patient level variables | ||||
| Female, ref. = male | 1.12 (1.02-1.22) | <0.030 | 1.12 (1.08-1.16) | <0.001 |
| Age, years | 1.04 (1.04-1.04) | <0.001 | 1.03 (1.02-1.03) | <0.001 |
| White race, ref. = Non-white | 0.99 (0.85-1.13) | 0.586 | -- | -- |
| Hispanic ethnicity, ref. = Non-Hispanic | -- | -- | 1.25 (1.21-1.29) | <0.001 |
| Medicaid, charity care, uninsured, ref. = Commercial insurance + Medicare | 1.03 (0.91-1.15) | 0.856 | 1.05 (0.95-1.16) | 0.357 |
| Site level variables | ||||
| Active intervention, ref. = Maintenance group | 1.08 (1.03-1.14) | 0.003 | 1.10 (1.40-1.17) | 0.002 |
| Patients with ≥1 missed opportunities, % | 0.95 (0.95-0.96) | <0.001 | 0.96 (0.95-0.96) | <0.001 |